TCT
This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures.
News | Heart Valve Technology | November 07, 2017
November 7, 2017 — Medtronic plc recently presented positive data for its self-expanding Intrepid transcatheter mitral...
News | Heart Valve Technology | November 07, 2017
November 7, 2017 — A new study has found that a pioneering device to repair heart valves is safe and effective, and can...
Study principal investigator Vladimir Ganyukov, M.D., Ph.D., head of interventional cardiology, State Scientific Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia, explaining the HREVS trial results at TCT 2017.
News | November 06, 2017 | Dave Fornell
November 6, 2017 — In the Hybrid REvascularization Versus Standards (HREVS) study that evaluated three different...
Feature | Cath Lab | November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found...
News | Heart Valve Technology | November 06, 2017
November 6, 2017 — One year follow-up data from the SCOUT I Early Feasibility Study for the Mitralign Trialign System...
Photo courtesy of Siemens Healthineers
News | Antiplatelet and Anticoagulation Therapies | November 06, 2017
November 6, 2017 — The first trial to evaluate the safety of dual antiplatelet therapy (DAPT) for less than 12 months...
FAME2 cost effectiveness of FFR guided PCI vs. medical therapy alone.
News | FFR Technologies | November 06, 2017
November 6, 2017 — Three-year data from the FAME 2 study show patients with coronary artery disease who underwent a...
News | Stents Drug Eluting | November 06, 2017
November 6, 2017 — Elderly patients undergoing percutaneous coronary intervention (PCI) often receive bare-metal stents...
News | Stents Drug Eluting | November 03, 2017
November 3, 2017 — Biotronik's Orsiro drug-eluting stent (DES) demonstrated high long-term safety and clinical...
Technology | FFR Technologies | November 03, 2017
November 3, 2017 — Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist RXi...
Feature | Atrial Fibrillation | November 02, 2017
November 2, 2017 – Five-year results from the PREVAIL Trial comparing left atrial appendage closure (LAAC) with the...
An illustration of the Sequent Please drug-coated balloon.
Feature | Drug-Eluting Balloons | November 02, 2017
November 2, 2017 — The treatment of in-stent restenosis (ISR) remains challenging in clinical practice. The DARE (Drug-...
News | Chronic Total Occlusion (CTO) | November 02, 2017
November 2, 2017 — Crossing the occlusion with a guidewire is often the most challenging part of chronic total...
Image courtesy of OrbusNeich
News | Stents Drug Eluting | November 01, 2017
November 1, 2017 — OrbusNeich reported results from the REDUCE trial in the Late-Breaking Clinical Trial session at the...
News | Stents Bifurcation | November 01, 2017
November 1, 2017 — The double kissing (DK) crush two-stent technique was associated with a lower rate of target lesion...
